Health :: It’s Three in a Row for Neath Port Talbot Hospital
Neath Port Talbot Hospital?s excellent record of providing quality care for the people and communities it serves has been recognised by the awarding of its third successive Charter Mark.
Neath Port Talbot Hospital?s excellent record of providing quality care for the people and communities it serves has been recognised by the awarding of its third successive Charter Mark.
A special research program at St. Joseph’s Hospital and Medical Center is providing a safe and vital research component to scientists in hopes of finding new treatments and cures for a variety of disorders.
Baroness Llora Finlay of Llandaff, professor of palliative medicine and chronic pain at the Velindre NHS trust, Cardiff, is presenting this year?s Marsden Lecture at the Royal Free. Baroness Finlay will speak on ?Quality at the end of Life? in a lecture on Thursday 16 November.
Royal Philips (NYSE: PHG, AEX: PHI) is introducing advances in its portfolio of leading oncology solutions to help physicians define their targets easily and effectively. Recognizing that console time is at a premium in busy imaging centers, Philips is announcing the availability of its Tumor LOC application on the workstation. The company is also unveiling Panorama 1.0T R/T?the first high field open MR simulator. These technologies are on display at the 48th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Philadelphia.
The survival of lung cancer patients increases by up to 92% of cases, within ten years of being diagnosed, when annual preventative low-dose radiation CAT screening is carried out. This is the conclusion of the International Early Lung Cancer Action Programme (IELCAP) in which the only Spanish-based centres taking part were the University Hospital and the Centre for Research into Applied Medicine (CIMA), both part of the University of Navarre.
Novartis announced plans to build an integrated biomedical Research & Development center in Shanghai’s Zhangjiang Hi-Tech Park that will become an integral part of the Group’s global research and development network.
Ear infections are among the most common diseases seen in pediatric practice. They have generally been considered bacterial diseases and are therefore usually treated with antibiotics. New research, published in the Dec. 15 issue of Clinical Infectious Diseases and currently available online, provides evidence that viruses are found in a great many ear infection cases and may complicate treatment.
Scientists at Children’s Hospital of Pittsburgh of UPMC have identified a protein that is critical to the development of inflammation during lung infection in patients with cystic fibrosis. The identification of this protein, called interleukin-23, is an important finding that gives researchers a specific target for developing new therapies.
Researchers who thought they had identified the bacterial perpetrator of the often severe disease caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) had better keep looking: Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have exonerated a toxin widely thought to be the guilty party.
Rhinoceros horns have long been objects of mythological beliefs. Some cultures prize them for their supposed magical or medicinal qualities. Others have used them as dagger handles or good luck charms. But new research at Ohio University removes some of the mystique by explaining how the horn gets its distinctive curve and sharply pointed tip.